This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
Gene Therapies for Muscle Growth, Erectile Dysfunction, and Radical Longevity
At the intersection of biotechnology and human health, a new frontier is emerging. Companies like Unlimited Bio are pushing the boundaries of gene therapy, exploring its potential to not only treat diseases but also enhance human performance and even extend lifespan. In this article, we'll delve into the world of gene therapies, examining their promise and risks, and exploring the implications of this rapidly evolving field.
Gene Therapies 101
Gene therapies typically work by introducing new genetic code into the body's cells. This code is then able to make proteins, which can have a wide range of effects on the body. Existing approved gene therapies have typically been developed for severe diseases in which the target proteins are either missing or mutated. However, several groups are now exploring gene therapies for healthy people, with the goal of enhancing their physical and mental abilities.
Muscle Growth and Endurance
One of the most promising areas of gene therapy research is muscle growth and endurance. Companies like Minicircle and Unlimited Bio are developing gene therapies that can increase muscle mass and enhance muscle repair. These therapies work by introducing genes that code for proteins involved in muscle growth and repair, such as follistatin. Follistatin is a protein that has many roles in the body, including regulating muscle growth and preventing muscle atrophy.
Vascular Endothelial Growth Factor (VEGF)
Another gene therapy being explored by Unlimited Bio is VEGF, a protein that encourages the growth of blood vessels. VEGF is known to support the growth of new blood vessels, which can improve blood flow and oxygen delivery to tissues. In the context of muscle growth and endurance, VEGF could potentially enhance muscle repair and recovery by improving blood flow to the muscles.
Erectile Dysfunction and Baldness
Unlimited Bio is also planning to trial its VEGF therapy for erectile dysfunction and baldness. The company believes that VEGF could potentially improve blood flow to the penis, leading to improved erectile function. Similarly, VEGF could potentially promote hair growth by improving blood flow to the scalp.
Risks and Challenges
While gene therapies hold great promise, they also pose significant risks and challenges. One of the main concerns is the potential for off-target effects, in which the therapy affects unintended parts of the body. Another concern is the potential for immune reactions, in which the body's immune system reacts to the therapy as if it were a foreign substance.
Ethics and Regulation
The ethics and regulation of gene therapies are also complex and contentious issues. Some argue that gene therapies should only be used to treat diseases, while others believe that they should be available for enhancement purposes. Regulatory agencies are still grappling with how to regulate gene therapies, and there is ongoing debate about the need for stricter regulations.
Real-World Applications
Despite the risks and challenges, gene therapies are already being used in real-world settings. Companies like Minicircle are offering gene therapies for muscle growth and endurance, and Unlimited Bio is planning to trial its VEGF therapy for erectile dysfunction and baldness. These therapies hold great promise for improving human health and performance, and they are likely to become increasingly important in the years to come.
Forward-Looking Thoughts
As gene therapies continue to evolve, we can expect to see significant advances in our understanding of human biology and disease. We may also see the development of new treatments for a wide range of diseases, as well as new technologies for enhancing human performance. However, we must also be aware of the potential risks and challenges associated with gene therapies, and we must work to ensure that they are developed and used responsibly.
Conclusion
Gene therapies hold great promise for improving human health and performance, but they also pose significant risks and challenges. As we move forward in this rapidly evolving field, it is essential that we prioritize responsible development and use of these therapies. By doing so, we can ensure that gene therapies are used to improve human lives, rather than to harm them.
Deep Dive
Biotechnology and Health
We're learning more about what vitamin D does to our bodies
The sunshine vitamin could affect your immune system and heart health.
By Jessica Hamzelouarchive page
Cloning isn't just for celebrity pets like Tom Brady's dog
Yes, you can pay $50,000 to clone a pet. But others are using the technology to rescue endangered species.
By Jessica Hamzelouarchive page
Here's why we don't have a cold vaccine. Yet.
Preventing the common cold is extremely tricky—but not impossible.
By Jessica Hamzelouarchive page
Here's the latest company planning for gene-edited babies
Entrepreneurs say it's time to safety-test designer baby technology.
By Antonio Regaladoarchive page
Stay connected
Illustration by Rose Wong
Get the latest updates fromMIT Technology Review
Discover special offers, top stories, upcoming events, and more.
Enter your email
Privacy PolicyThank you for submitting your email!
Explore more newsletters
It looks like something went wrong.
We’re having trouble saving your preferences.
Try refreshing this page and updating them one
more time. If you continue to get this message,
reach out to us at
[email protected] with a list of newsletters you’d like to receive.
